Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/58399 
Year of Publication: 
2012
Series/Report no.: 
Working Paper No. 12-8
Publisher: 
University of California, Department of Economics, Davis, CA
Abstract: 
We correlate competitive bidding and profits in symmetric independent private value first-price auctions with salivary testosterone, estradiol, progesterone, and cortisol in more than 200 subjects. Females bid significantly higher and earn significantly lower profits than males. Moreover, females on hormonal contraceptives bid significantly higher and earn significantly lower profits than males. Bids are significantly positively correlated and profits are significantly negatively correlated with salivary progesterone when controlling for gender, the use of hormonal contraceptives, and demographics. This also applies to the female but not to the male subsamples separately. It especially applies to naturally cycling females not using hormonal contraceptives and to females in the luteal phase of their natural menstrual cycle when progesterone usually peaks. Surprisingly, we have null findings for testosterone as well as estradiol and cortisol. Controlling for risk aversion does not diminish our positive finding for progesterone. Yet, we show that our finding may be due to subjects with imprudent bidding behavior (i.e., weakly dominated bids).
Subjects: 
Hormones
Testosterone
Estradiol
Progesterone
Cortisol
Steroids
Auctions
Gender
Competition
Aggression
Dominance
Risk-taking
Endocrinological economics
JEL: 
C72
C91
C92
D44
D81
D87
Document Type: 
Working Paper

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.